INVESTORS

Forms & Information

Issuers of corporate securities are required to complete Internal Revenue Service Form 8937 to report organizational actions, including nontaxable distributions that affect the basis of the securities involved in the organizational action. Form 8937 is supplemental information solely for the use of the intended recipient(s) and should not be relied upon as legal, tax, accounting, or similar advice. The recipient is urged to consult its own legal and tax advisors for any such matters as the Company does not provide any such advice.

Please note that Form 8937 was not filed for 2019 as all distributions were considered taxable dividends for U.S. tax reporting purposes.

CORPORATE GOVERNANCE

BOARD OF TRUSTEES

Thomas P. Majewski

Chairman, Interested Trustee

James R. Matthews

Interested Trustee

Scott W. Appleby

Independent Trustee

Kevin F. McDonald

Independent Trustee

Paul E. Tramontano

Independent Trustee

Jeffrey L. Weiss

Independent Trustee

OFFICERS

Thomas P. Majewski

Chief Executive Officer and Principal Executive Officer

Kenneth P. Onorio

Chief Financial Officer, Principal Accounting Officer and Chief Operating Officer

Nauman S. Malik

Chief Compliance Officer

Courtney B. Fandrick

Secretary

FAQ

 

FINANCIALS

PERFORMANCE

Fund Performance(1)

Period

Total Return (No Sales Load)

Total Return (Max. Sales Load)

6 Months

10.4%

2.9%

YTD

12.3%

4.8%

1 Year

12.3%

4.8%

Inception to Date

17.2%

9.3%

1. Returns are not annualized and returns are as of December 31, 2023. Inception date is June 1, 2022. Returns shown reflect the percent change in NAV per share from the beginning of the applicable period, plus the amount of any distribution per share declared in the period. All returns shown assume reinvestment of distributions pursuant to the Fund’s distribution reinvestment plan, are derived from unaudited financial information and are net of all Fund expenses, including general and administrative expenses, transaction related expenses, management fees, and incentive fees. Past performance is not indicative of, or a guarantee of, future performance. Returns listed as “(max sales charge)” assume payment of the full upfront sales charge at initial subscription (6.75%). Return information is not a measure used under GAAP. The returns have been prepared using unaudited data and valuations of the underlying investments in the Fund’s portfolio, which are estimates of fair value and form the basis for the Fund’s NAV. Valuations based upon unaudited reports may not correspond to realized value and may not accurately reflect the price at which assets could be liquidated. Performance reflects certain expense limitation and fee waiver arrangements in effect during the periods shown. Absent these arrangements, the Fund’s performance would have been lower. Certain expenses paid by Eagle Point Credit Management or its affiliates on the Fund’s behalf are subject to reimbursement by the Fund for up to three years (which reimbursement would have the effect of reducing the Fund’s performance). Performance does not reflect the impact of federal, state or local taxation to which an investor may be subject.

DISTRIBUTIONS

Ex-Date

Distributions per Share

1/30/2024

$0.078

12/28/2023

$0.078

11/29/2023

$0.078

10/30/2023

$0.078

9/28/2023

$0.075

8/30/2023

$0.075

7/28/2023

$0.075

6/29/2023

$0.072

5/30/2023

$0.074

4/27/2023

$0.074

3/30/2023

$0.077

2/27/2023

$0.077

1/30/2023

$0.075

12/29/2022

$0.075

11/29/2022

$0.076

10/28/2022

$0.077

9/29/2022

$0.079

8/31/2022

$0.074

7/29/2022

$0.074

SHARE PRICES

Date

NAV per Share

Brokerage Offering Price

Affiliated RIA Offering Price

Institutional Offering Price

     

12/31/2023

$10.23

$10.97

$10.31

$10.23

11/30/2023

$9.96

$10.68

$10.04

$9.96

10/31/2023

$10.00

$10.73

$10.08

$10.00

9/30/2023

$10.21

$10.95

$10.29

$10.21

8/31/2023

$10.19

$10.93

$10.27

$10.19

7/31/2023

$9.97

$10.69

$10.05

$9.97

6/30/2023

$9.70

$10.40

$9.77

$9.70

5/31/2023

$9.47

$10.16

$9.54

$9.47

4/30/2023

$9.81

$10.44

$10.01

$9.81

3/31/2023

$9.81

$10.44

$10.01

$9.81

     

2/28/2023

$10.18

$10.83

$10.39

$10.18

     

1/31/2023

$10.22

$10.87

$10.43

$10.22

     

12/31/2022

$9.97

$10.61

$10.17

$9.97

     

11/30/2022

$9.99

$10.64

$10.19

$9.99

     

10/31/2022

$10.02

$10.66

$10.22

$10.02

     

9/30/2022

$10.17

$10.82

$10.38

$10.17

     

8/31/2022

$10.48

$11.15

$10.69

$10.48

     

7/31/2022

$9.73

$10.35

$9.93

$9.73

     

6/30/2022

$9.78

$10.40

$9.98

$9.78

     

6/1/2022

$10.00

$10.64

$10.20

$10.00

     

PORTFOLIO INVESTMENTS

Top 10 UNDERLYING EXPOSURES

As of December 31, 2023

Top 10 Obligors

Sector 

% of Total

Asurion

Insurance

0.7% 

AthenaHealth

Healthcare Technology

0.6%

McAfee

Technology: Software & Services

0.6%

Ineos

Chemicals

0.5%

Ultimate Software Group

Technology: Software & Services

0.5%

Medline Industries

Healthcare Equipment & Supplies

0.5%

Virgin Media

Diversified Telecommunication Services

0.5%

TransDigm

Aerospace & Defense

0.5%

Culligan

Machinery

0.5%

AzkoNobel

Chemicals

0.5%

Total

 

5.4%

The information presented herein is on a look-through basis to the collateralized loan obligation, or “CLO”, equity held by the Fund as of December 31, 2023 (except as otherwise noted) and reflects the aggregate underlying exposure of the Fund based on the portfolios of those investments. The data is estimated and unaudited and is derived from CLO trustee reports received by the Fund relating to December 2023 and from custody statements and/or other information received from CLO collateral managers and other third party sources. Information relating to the market price of underlying collateral is as of month end; however, with respect to other information shown, depending on when such information was received, the data may reflect a lag in the information reported. As such, while this information was obtained from third party data sources, November 2023 trustee reports and similar reports, other than market price, it does not reflect actual underlying portfolio characteristics as of December 31, 2023 and this data may not be representative of current or future holdings. Industry categories are based on the S&P industry categorization of each obligor as reported in CLO trustee reports to the extent so reported. Certain CLO trustee reports do not report the industry category of all of the underlying obligors and where such information is not reported, it is not included in the summary look-through industry information shown. As such, the Fund’s exposure to a particular industry may be higher than that shown if industry categories were available for all underlying obligors. In addition, certain underlying obligors may be re‐classified from time to time based on developments in their respective businesses and/or market practices.

Eagle Point Institutional Income Fund & Subsidiaries

INVESTMENT PORTFOLIO DETAILS